Risperidone
PERSERIS, RISPERDAL, RISPERDAL CONSTA, RISPERDAL M-TAB, Rykindo, UZEDY
Atypical Antipsychotic
NADAC/unit
$0.0360
No Shortage
Tier 1: 566.0%
PA Req: 185.7%
25 Manufacturers
123 ANDAs
Risperidone treats schizophrenia, bipolar disorder, and related conditions by modulating dopamine and serotonin receptors.
vs. brand PERSERIS: Generic saves up to 100% per unit
Generic Manufacturers
AJANTA PHARMA LTDAMNEAL EU LTDAMNEAL PHARMACEUTICALSAMNEAL PHARMACEUTICALS LLCANI PHARMACEUTICALS INCAPOZEAL PHARMACEUTICALS INCAUROBINDO PHARMA LTDCHARTWELL MOLECULAR HOLDINGS LLCDR REDDYS LABORATORIES LTDINDIVIOR INCIPCA LABORATORIES LTDJANSSEN PHARMACEUTICALS INCJUBILANT CADISTA PHARMACEUTICALS INCJUBILANT GENERICS LTDNANOMI BVNOVITIUM PHARMA LLCPH HEALTH LTDPRINSTON PHARMACEUTICAL INCRENATA PLCRISING PHARMA HOLDINGS INCSANDOZ INCSENORES PHARMACEUTICALS INCSHANDONG LUYE PHARMACEUTICAL CO LTDSUN PHARMACEUTICAL INDUSTRIES LTDTEVA NEUROSCIENCE INCTEVA PHARMACEUTICALS USA INCTORRENT PHARMACEUTICALS LTDTRIS PHARMA INCZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.